Up Next
Back to Show
PBS News Hour
Why FDA approval of sickle cell gene therapy is a ‘big deal’
Sickle cell disease is a chronic, debilitating condition that affects nearly 100,000 Americans, most of them with African ancestry. Now, the FDA has approved a groundbreaking treatment for it that uses the gene-editing tool CRISPR. John Yang speaks with Yale School of Medicine assistant professor Dr. Cece Calhoun and New York Times reporter Gina Kolata to learn more.
Sign up now for inspiring and thought-provoking media delivered straight to your inbox.
Support Provided By
57:46
June 30, 2025 - PBS News Hour full episode
26:45
June 29, 2025 - PBS News Weekend full episode
26:45
June 28, 2025 - PBS News Weekend full episode
57:46
June 27, 2025 - PBS News Hour full episode
57:46
June 26, 2025 - PBS News Hour full episode
57:46
June 25, 2025 - PBS News Hour full episode
57:46
June 24, 2025 - PBS News Hour full episode
56:45
June 23, 2025 - PBS News Hour full episode
26:45
June 22, 2025 - PBS News Weekend full episode
26:45
June 21, 2025 - PBS News Weekend full episode
56:44
June 20, 2025 - PBS News Hour full episode
57:46
June 19, 2025 - PBS News Hour full episode